BridgeMD
New treatment option for Warts Hand
Official title Tirbanibulin for Pediatric Warts
ClinicalTrials.gov ID: NCT06791525
What this study is testing
What is Tirbanibulin ointment 1%?
Tirbanibulin ointment 1% is an investigational medicine, given as a treatment applied to the skin, being studied as a potential treatment for warts hand.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Warts are common, benign skin lesions caused by the human papillomavirus (HPV). Treatment is challenging, particularly in the pediatric population, where standard modalities such as cryotherapy and intralesional immunotherapy are poorly tolerated.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 18
You may be able to join if
- Age 8-18
- Subject and their legally authorized representative must be able to understand and be willing to adhere to all protocol requirements and voluntarily...
- Subject is judged to be in good health as determined by the Principal Investigator, based upon the results of the screening assessments and medical...
- Diagnosis of warts on the hands
- Wart count on the hands and 3-10
You likely can't join if
- Wart duration \>2 years.
- More than 10 warts in non-hand areas.
- Total wart surface area on the hands bigger than 100 cm2
- Prior treatment failure with the following modalities: 1\. intralesional immunotherapy 2. intralesional bleomycin, 5-fluorouracil, methotrexate 3...
The study team makes the final eligibility decision.
Where it's taking place
- New City, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New City, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.